Mamta Jain, MD, MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gilead Sciences
    Topic:
    HIV, Hepatits B, COVID-19
    Date added:
    Date updated:
    03/31/2025
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ACTHIV
    Topic:
    HIV
    Date added:
    01/31/2022
    Date updated:
    03/31/2025
    Relationship end date:
    05/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Laurent
    Topic:
    COVID-19
    Date added:
    05/01/2023
    Date updated:
    03/31/2025
    Relationship end date:
    08/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Abbvie
    Topic:
    Hepatitis C, HIV
    Date added:
    03/23/2024
    Date updated:
    03/31/2025
    Relationship end date:
    03/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    HIV
    Date added:
    03/23/2024
    Date updated:
    03/31/2025
    Relationship end date:
    06/03/2024
Return to 225 HIV Lecture Session “Primary Care Guidelines” (040225)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.